Assessment of low-grade glioma treatment response remains as much of a challenge as the treatment itself. Proton magnetic resonance spectroscopy (1H-MRS) and imaging were incorporated into a study ...

Due to the infiltrative nature of gliomas, tumor margin detection is often difficult, and current intraoperative visualization methods are limited. Time-resolved fluorescence spectroscopy (TRFS) has ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas. ScienceDaily . Retrieved May 16, 2025 from www.sciencedaily.com / releases / 2018 / 05 / 180518164050.htm ...

Proton magnetic resonance spectroscopy (MRS) of the brain can detect 2-hydroxyglutarate (2HG), the oncometabolite produced in neoplasms harboring a mutation in the gene coding for isocitrate ...

In a double-blind, phase 3 trial, we randomly assigned patients with residual or recurrent grade 2 IDH-mutant glioma who had undergone no previous treatment other than surgery to receive either ...

Low Grade Glioma. (Left) Flair coronal MRI; (Right) Flair parasagittal MRI. Note the lesion in the left frontal lobe anterior to the precentral sulcus in the superior frontal gyrus. This lesion did ...

image: Three-dimensional magnetic resonance spectroscopy imaging reveals a decrease in tumor levels of 2-hydroxyglurate ... "Gliomas are aggressive, ...

Glioma is a type of brain cancer. It is the most common type of brain cancer in adults. There are different subtypes of glioma. Learn more.

An increasing amount of research shows that LAT1/4F2hc is over-expressed in a variety of human tumors. Is it useful as a prognostic marker and/or potential therapeutic target in gliomas?

Brain stem gliomas are growths that begin in the glial cells of the brain stem. Doctors can diagnose brain stem glioma using neurological exams and scans. Treatment may involve chemotherapy ...

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma. New England Journal of Medicine, 2023; DOI: 10.1056/NEJMoa2304194; Cite This Page: MLA; APA; Chicago; ...